Annual report pursuant to Section 13 and 15(d)

WARRANTS (Tables)

v3.20.2
WARRANTS (Tables)
12 Months Ended
Mar. 31, 2020
WARRANTS  
Schedule of continuity schedule

The following is a continuity schedule of the Company’s common share purchase warrants:

 

 

 

 

 

 

 

    

 

    

Weighted 

 

 

Number of

 

Average

 

 

Warrants

 

Exercise Price

 

 

 

 

($)

Outstanding and exercisable, March 31, 2018

 

365,974

 

53.19

Issued in connection with anti-dilution provision connected warrant transaction

 

67,952

 

55.71

Issued in connection with anti-dilution provision connected warrant transaction

 

6,305

 

34.50

Issued in connection with anti-dilution provision connected warrant transaction

 

52,590

 

38.91

Expired

 

(204,304)

 

(51.85)

Outstanding and exercisable, March 31, 2019

 

288,517

 

40.27

Expired

 

(163,483)

 

(38.91)

Outstanding and exercisable, March 31, 2020

 

125,034

 

20.07

 

Schedule of common share purchase warrants outstanding

The following is a summary of common share purchase warrants outstanding as of March 31, 2020:

 

 

 

 

 

 

Exercise

    

Number of

    

 

Price ($)

 

Warrants

 

Expiry Date

90.00

 

15,658

 

March 31, 2023

37.50

 

2,667

 

June 27, 2020

9.375

 

64,025

 

August 14, 2022

9.375

 

42,684

 

March 31, 2022

 

 

125,034